1[1]Buenting JE,Smith TL, Holmes DK. Giant pleomorphic adenoma of the parotid gland: case report and review of the literature. Ear Nose Throat J. 1998,77(8): 634, 637-638, 640
2[2]Klijanienko J, Servois V, Jammet P, et al. Pleomorphic adenoma. Am J Surg Pathol,1998,22(6):772-773
3[3]Palacios E, Valvassori G. Parotid mass: pleomorphic adenoma(mixed tumor). Ear Nose Throat J,1999,78(10):746-747
4[4]Myssiorek D. Removal of the inferior half of the superficial lobe is sufficient to treat pleomorphic adenoma in the tail of the parotid gland. Arch Otolaryngol Head Neck Surg,1999,125(10): 1164-1165
5[8]Yasumoto M, Sunaba K, Shibuya H, et al. Recurrent pleomorphic adenoma of the head and neck. Neuroradiology,1999,41(4),300-304
6[9]Junquera L, Alonso D, Sampedro A, et al. Pleomorphic adenoma of the salivary glands: prospective clinicopathologic and flow cytometric study. Head Neck,1999,21(7):652-656
8Kerawala C.J, McAloney N, Stassen LF. Prospective randomised trial of the benefits of a stemocleidomastoid flap after superficial parotidectomy [ J]. Br J Oral Maxillofac Surg,2002,40(6) :468-472.
9Kyrmizakis DE, Pangalos A, Papadakis CE, et al. The use of botulinum toxin type A in the treatment of Frey and crocodile tears syndromes[ J]. J Oral Maxillofac Surg, 2004,62 (7) :840-844.
10Birch JF, Varma SK, Narula AA. Botulinum toxoid in the management of gustatory sweating( Frey's syndrome)after superficial parotidectomy[ J ]. Br J Plast Surg, 1999,52 (3) :230-231.
